Engineering of Biomaterials for Drug Delivery Systems

Beyond Polyethylene Glycol
Erscheinungsjahr 2018
ISBN: 978-0-08-101750-0
Verlag: Elsevier Science & Technology

Buch, Englisch, 404 Seiten, Format (B × H): 235 mm x 158 mm, Gewicht: 778 g

Reihe: Woodhead Publishing Series in Biomaterials

Engineering of Biomaterials for Drug Delivery Systems: Beyond Polyethylene Glycol examines the combined issues of PEGylation and viable biomaterials as alternatives. With a strong focus on polymeric biomaterials, the book first reviews the major issues associated with PEGylation and its use in vivo. Chapters then focus on alternative polymer systems for drug delivery systems. Finally, nanoparticles and future perspectives are examined. This book is a valuable resource for scientists and researchers in biomaterials, pharmaceuticals and nanotechnology, and all those who wish to broaden their knowledge in this field.

Zielgruppe

<p>Researchers and scientists in biomaterials for drug delivery, biomaterials synthesis, pharmaceuticals and nanotechnology</p>

Autoren/Hrsg.

Parambath, Anilkumar

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizin, Gesundheitswesen Medizintechnik, Biomedizintechnik, Medizinische Werkstoffe
• Technische Wissenschaften Sonstige Technologien | Angewandte Technik Medizintechnik, Biomedizintechnik

Inhaltsverzeichnis

1. PEGylated 'stealth' liposomes
2. PEGylated proteins
3. PEGylation and anti-PEG antibodies

4. Poly (zwitterions)

5. Poly (glycerols)
6. Poly (oxazolines)
7. Poly (aminoacids)
8. Poly (acylamides) and related systems
9. Poly (vinylpyrrolidones)
10. Sugar based systems (trehalose)
11. Polypeptide alternatives (PASylation and XTen) to PEG

12. DDS based on non-immunogenic biopolymers
13. Non-PEGylated nanoparticles

14. Summary and future perspectives

Über Autor(innen)

Parambath, Anilkumar
Dr Anilkumar Parambath is Senior R&D Manager of YTY Group, Indorama Corp., Perak, Malaysia. Prior to this, he was R&D Manager, Science & Technology at Unilever (2021-2024); Senior Manager and Head of Capsules Product R&D, ACG Capsules, Mumbai, India (2018-2021) and Principal Investigator for Performance and Specialty Materials at Syngene International Ltd, Bangalore India (2017-2018), where he worked on developing various elastomers, silicones, acrylics and other polymers for biomedical applications. He completed his PhD in Chemistry (Polymer Science) at the University of Kerala, India, and spent 7 years conducting post-doctoral research at Clemson University, USA, French atomic Energy Commission (CEA), France, and the University of British Columbia, Canada. HIs expertise is in polymer science, materials science, green chemistry, nanotechnology, nanomedicine, and biomaterials science. Dr. Parambath has edited three books on polymer biomaterials in drug delivery applications, including two with Elsevier, and has published many books chapters and journal articles. He has two patents to his name. In 2024, he was recognized by the American Chemical Society (ACS) as a Sustainability Star.